Studies from 1992 show that hormonal treatment for early stage breast cancer is as good as or better than chemotherapy. A 2018 study (TAILORx) using analysis of 21 genes that costs $4,620 per test arrives at the same conclusion. BUT THIS GENE INFORMATION DOES NOT PROVIDE ANY NEW TREATMENT INFORMATION.
The federal government, the biggest payer of cancer care, made cancer costs soar because Medicare pays an extra $6500 a year when chemotherapy is given to a patient in a hospital owned facility. Private insurers also pay a higher premium for care delivered in a hospital setting. The costs will keep spiraling upward because of Government intrusion and clever lobbyists, forcing cancer patients from private practitioners to hospital owned facilities incurring much higher costs.